Shobha Shukla, Citizen News Service - CNS
"It is not only about preventing new
births of thalassemic infants; about chelation, about blood transfusion
and about availability of services needed; but also about preventing
complications related to Thalassaemia. We cannot take half baked measures. Because if the
patient dies prematurely, it will be a huge waste of national
resources—10-15 years worth of investment just goes down the drain.
Inadequate chelation and blood transfusion can result in hospitalization
in intensive care and cost a lot. Patients should not only be kept
alive but also grow up to be productive members of society. Besides the
expertise, we also need experienced and enthusiatic physicians, and
cooperative patients who are willing to take treatment as they grow up" said Dr Michael Angastiniotis, Medical Advisor to Thalassaemia
International Federation.
| Dr Michael Angastiniotis (CNS image library) |












